Rig-G is a growth inhibitory factor of lung cancer cells that suppresses STAT3 and NF-κB

Area of Science:

• Oncology
• Molecular Biology
• Gene Expression

Background:

• The retinoic acid-induced G (Rig-G) gene is expressed in various cancer cells, including lung cancer.
• Its role as a tumor suppressor in lung cancer remains largely uncharacterized.

Purpose of the Study:

• To investigate the function of Rig-G in lung cancer.
• To elucidate the molecular mechanisms underlying Rig-G's potential antitumor effects.

Main Methods:

• Ectopic expression and knockdown of Rig-G in lung cancer cells.
• Cell proliferation and colony formation assays.
• Transcriptome and pathway analyses, including NF-κB signaling investigation.

Main Results:

• Ectopic Rig-G expression significantly decreased lung cancer cell proliferation and inhibited tumor growth.
• Rig-G knockdown modestly increased cell proliferation and colony formation.
• Rig-G impacts growth signaling pathways, notably inhibiting NF-κB activity by suppressing STAT3, downregulating miR21 and miR181b-1, and activating the PTEN/Akt and CYLD/IκB signaling axis.

Conclusions:

• Rig-G functions as a tumor suppressor in lung cancer.
• Rig-G exerts its antitumor effects by modulating critical signaling pathways, offering a potential therapeutic strategy for lung cancer.